Global Angiography Devices Market 2017-2021


#1027803

117pages

Technavio

$ 3500

In Stock

About Angiography Devices

Coronary artery disease (CAD), a type of cardiovascular disease, is one of the leading causes of deaths worldwide, which is accounting for high number of heart attacks, stroke, and death. The formation of plaque in the blood vessels can cause CAD. The disease causes narrowing of the blood vessels, which interrupts normal blood flow and may lead to ischemic stroke. For treatment, physicians may perform angioplasty using balloon catheters with or without stents to open the arteries and improve the blood flow. These diseases are related to the heart and blood vessels. Coronary artery disease causes blockage in the artery characterized by the deposition of fatty substances that leads to the narrowing of blood vessels, and thereby interrupting the supply of normal blood flow to the heart. In an August 2015 report, the Centers of Disease Control and Prevention (CDC) estimated that coronary artery disease causes 370,000 deaths annually.

Technavios analysts forecast the global angiography devices market to grow at a CAGR of 6.06% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global angiography devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of angiography devices.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Angiography Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Laboratories
Boston Scientific
Cardinal Health
Medtronic

Other prominent vendors
Abiomed
Aachen Resonance
Acrostak
Advansource Biomaterials
AGA Medical
Allium Medical
Alvimedica Medical devices
AMG International
Angioslide
AngioDynamics
Arstasis
Arthesys
Asahi Intecc
Atrium Medical
AV Medical
B. Braun Melsungen
Beijing Puyishengji Medical Technology
Biophan Technologies
Biosense Webster
Biotronik
BrosMed
Cardiac Science
CardiacAssist
Cardica
Cardio-Flow
Cardionovum
Claret Medical
Contego Medical
Cook Group
Cryolife
Endocor
Edward Lifesciences
Essential Medical
GaltNeedleTech
Kaneka Medix
InSeal Medical
Innovative Cardiovascular Solutions
JOTEC
Keystone Heart
Lepu Medical Technology
Medinol
Medeon Biodesign
Morris Innovative
Merit Medical Systems
Meril Life Sciences
MicroPort Scientific
Natec Medical
OptiMed
QT Vascular
SHOCKWAVE Medical
Smiths Medical
Spectranetics
STENTYS
Svelte medical
Teleflex
Tokai Medical
Transverse Medical
Transluminal Technologies
US Endovascular
Vascular Closure Systems
Vasorum
Vivasure Medical
Volcano

Market driver
Rising incidences of cardiac diseases increasing adoption of angiography devices
For a full, detailed list, view our report

Market challenge
Lack of product differentiation leading to marginal profits
For a full, detailed list, view our report

Market trend
Transforming marketing and sales strategies
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.




Table of Contents

PART 01: Executive summary

PART 02: Scope of the report


Market overview
Top-vendor offerings


PART 03: Market research methodology


Research methodology
Economic indicators


PART 04: Introduction


Key market highlights


PART 05: Market landscape


Market overview
Market size and forecast
Five forces analysis


PART 06: Market segmentation by product


Angioplasty balloons market
Vascular closure device
Vascular guidewire
Embolic protection devices


PART 07: Market segmentation by end user


ASCs
Hospitals
Physicians' offices


PART 08: Geographical segmentation


Angiography devices market in Americas
Angiography devices market in EMEA
Angiography devices market in APAC


PART 09: Market drivers


Rising incidences of cardiac diseases increasing adoption of angiography devices
Presence of specialized cardiologists
Outsourcing research to CROs
Venture capitals for market entry of start-ups
Minimally invasive procedures with improved medical imaging


PART 10: Impact of drivers

PART 11: Market challenges


High cost of angiography devices and procedures
Product recalls
Lack of product differentiation leading to marginal profits


PART 12: Impact of drivers and challenges

PART 13: Market trends


Transforming marketing and sales strategies
Increase in M&A
Emergence of digital cath labs in hospitals


PART 14: Vendor landscape


Competitive landscape analysis


PART 15: Key vendor analysis


Abbott Laboratories
Boston Scientific
Cardinal Health
Medtronic
Key companies to watch
Other prominent vendors


PART 16: Appendix5


List of abbreviations


PART 17: Explore Technavio
List of Exhibits

Exhibit 01: Product offerings

Exhibit 02: Global angiography devices market: Overview

Exhibit 03: Angioplasty devices market by product type 2016

Exhibit 04: Scope of angiography devices market based on geography 2017-2021

Exhibit 05: Global angiography devices market: Impact assessment

Exhibit 06: Global angiography devices market 2016-2021 ($ billions)

Exhibit 07: Few key market developments

Exhibit 08: Five forces analysis

Exhibit 09: Global angiography devices market by product 2016-2021 ($ billions)

Exhibit 10: Market overview: Angioplasty balloon

Exhibit 11: Key focus and strategies of companies: Angioplasty balloon

Exhibit 12: Global angioplasty balloons market 2016-2021 ($ billions)

Exhibit 13: Clinical study: Difference in stenosis of DEBs

Exhibit 14: Market overview: Vascular closure device

Exhibit 15: Key focus and strategies of companies: Vascular closure device

Exhibit 16: Global vascular closure devices market 2016-2021 ($ billions)

Exhibit 17: Market overview and focus of companies: Vascular guidewire

Exhibit 18: Key focus and strategies of companies: Vascular guidewire

Exhibit 19: Global vascular guidewires market 2016-2021 ($ billions)

Exhibit 20: Market overview and focus of companies: Embolic protection device

Exhibit 21: Key focus and strategies of companies: Embolic protection device

Exhibit 22: Global embolic protection devices market 2016-2021 ($ billions)

Exhibit 23: Some advanced embolic protection devices

Exhibit 24: New entrants and milestone achieved by them

Exhibit 25: Embolic protection devices: Clinical studies with positive results

Exhibit 26: Global angiography devices market in 2016

Exhibit 27: Comparison of reimbursement for ASCs, hospital out-patient departments, and physicians' offices in US

Exhibit 28: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe

Exhibit 29: Global angiography devices market by geography in 2016 and 2021 ($ billions)

Exhibit 30: Market overview: Angiography devices market in Americas

Exhibit 31: Number of coronary angiography in few countries in Americas 2013

Exhibit 32: Angiography devices market in Americas 2016-2021 ($ billions)

Exhibit 33: Angiography devices market in Americas: Metrics analysis for various countries

Exhibit 34: Market overview: Angiography devices market in the US

Exhibit 35: Implements amended in ACA in US (in 2010 and 2014-2015)

Exhibit 36: Impact of Accountable Care Organization (ACO) and ACA on angiography devices

Exhibit 37: Market overview: Angiography devices market in EMEA

Exhibit 38: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013

Exhibit 39: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013 (in 100,000 population)

Exhibit 40: Angiography devices market in EMEA 2016-2021 ($ billions)

Exhibit 41: Angiography devices market in EMEA: Metrics analysis by countries

Exhibit 42: Market overview: Angiography devices market in Israel

Exhibit 43: Market overview: Angiography devices market in APAC

Exhibit 44: Angiography devices market in APAC 2016-2021 ($ billions)

Exhibit 45: Market overview: Angiography devices market in India

Exhibit 46: CROs that helped companies receive regulatory approvals for PCI devices

Exhibit 47: CROs that helped companies receive regulatory approvals for PCI devices

Exhibit 48: New market entrants

Exhibit 49: Impact of drivers

Exhibit 50: Product recalls: Angiography devices

Exhibit 51: Impact of drivers and challenges

Exhibit 52: Marketing and sales strategies of large and small companies

Exhibit 53: Acquisitions by some companies

Exhibit 54: Competitive structure analysis of global angiography devices market 2016

Exhibit 55: Competitive landscape analysis of global angiography devices market 2016

Exhibit 56: Abbott Laboratories: Strength assessment

Exhibit 57: Abbott Laboratories: Strategy assessment

Exhibit 58: Abbott Laboratories: Opportunity assessment

Exhibit 59: Boston Scientific: Strength assessment

Exhibit 60: Boston Scientific: Strategy assessment

Exhibit 61: Boston Scientic: Opportunity assessment

Exhibit 62: Cardinal Health: Strength assessment

Exhibit 63: Cardinal Health: Strategy assessment

Exhibit 64: Cardinal Health: Opportunity assessment

Exhibit 65: Medtronic: Strength assessment

Exhibit 66: Medtronic: Strategy assessment

Exhibit 67: Medtronic: Opportunity assessment

Exhibit 68: Key companies to watch

Exhibit 69: Other prominent vendors